Yimin Jiang

940 total citations
26 papers, 682 citations indexed

About

Yimin Jiang is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Yimin Jiang has authored 26 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Yimin Jiang's work include Pain Mechanisms and Treatments (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Yimin Jiang is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Yimin Jiang collaborates with scholars based in China, United States and Hong Kong. Yimin Jiang's co-authors include Ju‐Xian Song, Jia Ye, J. R. Lupton, Robert S. Chapkin, James N. Derr, Harold M. Aukema, Laurie A. Davidson, Karen TenDyke, Nenggui Xu and Chunzhi Tang and has published in prestigious journals such as PLoS ONE, Cancer Research and Brain Research.

In The Last Decade

Yimin Jiang

26 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yimin Jiang China 15 349 104 95 79 78 26 682
Rubén Martín Spain 13 311 0.9× 72 0.7× 69 0.7× 46 0.6× 74 0.9× 18 679
Lanqiu Zhang China 17 318 0.9× 71 0.7× 97 1.0× 26 0.3× 63 0.8× 38 714
Hyun‐Jeung Yu South Korea 13 274 0.8× 78 0.8× 71 0.7× 25 0.3× 133 1.7× 29 655
Xiaonan Zhu China 18 450 1.3× 60 0.6× 72 0.8× 49 0.6× 63 0.8× 40 768
Guangchun Sun China 17 464 1.3× 55 0.5× 99 1.0× 39 0.5× 54 0.7× 30 768
Tianfei Luo China 15 501 1.4× 56 0.5× 79 0.8× 47 0.6× 59 0.8× 26 848
Amos C. Hung Taiwan 17 327 0.9× 63 0.6× 111 1.2× 34 0.4× 173 2.2× 33 749
Tung‐Yuan Lai Taiwan 15 283 0.8× 87 0.8× 106 1.1× 20 0.3× 56 0.7× 21 655
Yue Jia China 17 432 1.2× 112 1.1× 59 0.6× 16 0.2× 56 0.7× 28 752

Countries citing papers authored by Yimin Jiang

Since Specialization
Citations

This map shows the geographic impact of Yimin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Jiang more than expected).

Fields of papers citing papers by Yimin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Jiang. The network helps show where Yimin Jiang may publish in the future.

Co-authorship network of co-authors of Yimin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yimin Jiang. A scholar is included among the top collaborators of Yimin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimin Jiang. Yimin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qin, Xiaoli Gao, Tianyu Wang, et al.. (2022). Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation. Brain Research. 1800. 148187–148187. 1 indexed citations
2.
Jiang, Yimin, Mei‐Hua Liao, Huan Wang, et al.. (2022). Electroacupuncture ameliorates cerebrovascular impairment in Alzheimer's disease mice via melatonin signaling. CNS Neuroscience & Therapeutics. 29(3). 917–931. 11 indexed citations
3.
Huang, Wen, Jin Zhou, Juanjuan Guo, et al.. (2021). Dexamethasone induces an imbalanced fetal-placental-maternal bile acid circulation: involvement of placental transporters. BMC Medicine. 19(1). 87–87. 21 indexed citations
4.
Wu, Yueguo, Rujia Mi, Wenzhao Liu, et al.. (2021). ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Molecular Therapy — Nucleic Acids. 26. 135–147. 69 indexed citations
5.
Wang, Ding, Hua Yang, Yingying Liang, et al.. (2019). Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism. Neurochemical Research. 44(12). 2786–2795. 7 indexed citations
6.
Gao, Xiaoli, Qi Sun, Weiwei Zhang, et al.. (2018). Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice. Inflammation Research. 67(4). 363–370. 4 indexed citations
7.
Yang, Hua, Qi Sun, Yingying Liang, et al.. (2018). Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice. Regulatory Toxicology and Pharmacology. 94. 108–114. 6 indexed citations
8.
Huang, Kuan‐Chun, Zhihong Chen, Yimin Jiang, et al.. (2016). Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61. Molecular Cancer Therapeutics. 15(6). 1208–1216. 55 indexed citations
9.
10.
Zhang, Weiwei, Qi Sun, Xiaoli Gao, et al.. (2013). Anti-Inflammation of Spirocyclopiperazinium Salt Compound LXM-10 Targeting α7 nAChR and M4 mAChR and Inhibiting JAK2/STAT3 Pathway in Rats. PLoS ONE. 8(6). e66895–e66895. 24 indexed citations
11.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo. Bioorganic & Medicinal Chemistry Letters. 21(6). 1634–1638. 12 indexed citations
12.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1639–1643. 16 indexed citations
13.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorganic & Medicinal Chemistry Letters. 21(6). 1630–1633. 16 indexed citations
14.
Zhao, Xia, et al.. (2010). Antinociceptive effect of spirocyclopiperazinium salt compound LXM-15 via activating peripheral α7 nAChR and M4 mAChR in mice. Neuropharmacology. 60(2-3). 446–452. 14 indexed citations
15.
Shen, Yongchun, Roch P. Boivin, Naoki Yoneda, et al.. (2010). Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III. Bioorganic & Medicinal Chemistry Letters. 20(10). 3155–3157. 31 indexed citations
16.
Kuznetsov, Galina, Qunli Xu, Karen TenDyke, et al.. (2009). Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Molecular Cancer Therapeutics. 8(5). 1250–1260. 85 indexed citations
17.
Ye, Jia, et al.. (2009). Anti-inflammatory effect of the spirocyclopiperazinium compound LXM-10 in mice and rats. European Journal of Pharmacology. 626(2-3). 290–296. 2 indexed citations
18.
Ji, Dengbo, et al.. (2009). Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice. BMC Complementary and Alternative Medicine. 9(1). 20–20. 16 indexed citations
19.
Nomoto, K., Jiayi Wu, Yimin Jiang, et al.. (2004). Novel proteasome inhibitors show potent anti-tumor efficacy. Cancer Research. 64. 925–925. 1 indexed citations
20.
Davidson, Laurie A., Yimin Jiang, James N. Derr, et al.. (1994). Protein Kinase C Isoforms in Human and Rat Colonic Mucosa. Archives of Biochemistry and Biophysics. 312(2). 547–553. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubén Martín Breakdown of academic impact, for papers by Lanqiu Zhang Breakdown of academic impact, for papers by Hyun‐Jeung Yu Breakdown of academic impact, for papers by Xiaonan Zhu Breakdown of academic impact, for papers by Guangchun Sun Breakdown of academic impact, for papers by Tianfei Luo Breakdown of academic impact, for papers by Amos C. Hung Breakdown of academic impact, for papers by Tung‐Yuan Lai Breakdown of academic impact, for papers by Yue Jia
Rankless by CCL
2026